45 results match your criteria: "Magee-Women's Hospital of the University of Pittsburgh[Affiliation]"
J Arthroplasty
November 2024
Arthritis and Arthroplasty Design Group, The Bone and Joint Center, Magee Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Department of Orthopaedic Surgery, Department of Bioengineering, and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.
Background: Periprosthetic joint infections (PJIs) are common and serious complications following knee and hip arthroplasty. Our previous retrospective study suggested extended antibiotics following debridement, antibiotics, and implant retention (DAIR) decreased failure rates and were not associated with increased adverse events (AEs) as compared to a standard 6 weeks of antibiotic therapy. Further, extended antibiotics beyond one year did not provide additional benefits.
View Article and Find Full Text PDFInt Orthop
April 2024
The Bone and Joint Center, Magee Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Purpose: Dislocation following total hip arthroplasty (THA) remains a significant clinical problem and can occur even with optimal implant alignment. We hypothesized that different patterns of pelvic flexion/extension (PFE) during daily activities may influence acetabular alignment and contribute to impingement and instability following THA. Recently, there has been an increased interest in spinopelvic alignment and its impact on THA.
View Article and Find Full Text PDFJ Orthop Res
March 2024
Arthritis and Arthroplasty Design Group, The Bone and Joint Center, Magee Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
The aim of this study was to assess the viability of four Staphylococcal bacteriophages when exposed to different concentrations of commonly used lavage solutions in the surgical treatment of prosthetic joint infections (PJI). Four tailed Staphylococcal bacteriophages and six different lavage solutions (chlorhexidine 4%, hydrogen peroxide 3%, acetic acid 3%, povidone iodine 10%, sodium hypochlorite 0.5%, and Vashe solution) at 100%, 1%, and 0.
View Article and Find Full Text PDFUrogynecology (Phila)
December 2022
University of Wisconsin School of Medicine and Public Health, Department of Obstetric and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Madison, WI.
Importance: There is a lack of high-quality long-term follow-up regarding pessary treatment. Most studies are case series or retrospective with a small sample size and short-term follow-up.
Objectives: This study aimed to evaluate differences in women who continue versus discontinue pessary use and the effectiveness, quality of life, and safety associated with pessary management at 1 year.
PLoS Negl Trop Dis
October 2022
Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Rift Valley fever (RVF) is a disease of animals and humans associated with abortions in ruminants and late-gestation miscarriages in women. Here, we use a rat model of congenital RVF to identify tropisms, pathologies, and immune responses in the placenta during vertical transmission. Infection of late-gestation pregnant rats resulted in vertical transmission to the placenta and widespread infection throughout the decidua, basal zone, and labyrinth zone.
View Article and Find Full Text PDFPLoS One
September 2022
Department of Orthopedic Surgery, Arthritis and Arthroplasty Design Group, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
Arthroplast Today
February 2022
The Bone & Joint Center, Magee Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA.
Background: Adverse local tissue reaction (ALTR) is a recognized complication of total hip arthroplasty (THA) with metal-on-polyethylene (MoP) bearing surface implants. Specific models of THA implants have been identified as having a higher incidence of ALTR. The purpose of this study is to determine if serum metal levels, patient symptoms, implant factors, and imaging findings can be predictive of ALTR within this high-risk population.
View Article and Find Full Text PDFFemale Pelvic Med Reconstr Surg
June 2021
Magee Women's Hospital of the University of Pittsburgh, Magee Women's Research Institute, Pittsburgh, PA.
Objective: Using the American Urogynecologic Society multicenter Pelvic Floor Disorder Registry for Research, we (1) compared generic quality of life (QOL) in women planning pelvic organ prolapse (POP) treatment (surgery vs pessary), (2) correlated generic and condition-specific QOL scores, and (3) identified associations between generic QOL and other factors.
Methods: This cross-sectional analysis assessed generic physical and mental QOL using the Patient-Reported Outcomes Measurement Information System Global Health Scale at baseline. Global Physical and Mental T-scores center on a representative US population sample (mean [SD], 50 [10]; higher scores, better health).
CA Cancer J Clin
July 2021
Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, Missouri.
The American Joint Committee on Cancer (AJCC) tumor, node, metastasis (TNM) staging for all cancer sites has been periodically updated as a published manual for many years. The last update, the eighth edition AJCC Cancer Staging Manual went into use on January 1, 2018. The AJCC has since restructured and updated its processes, and all AJCC staging-related data are now housed on its new application programming interface.
View Article and Find Full Text PDFJ Arthroplasty
July 2021
The Bone & Joint Center, Magee Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; Arthritis and Arthroplasty Design Lab, Department of Orthopaedic Surgery, University of Pittsburgh; Department of Bioengineering, and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA.
Background: Diagnosis of adverse local tissue reaction (ALTR) in metal-on-polyethylene (MoP) total hip arthroplasty (THA) secondary to head-neck taper corrosion is challenging. The purpose of this study is to compare differences between asymptomatic and symptomatic ALTR in an observational cohort, including presentation, metal ion differences, and metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) findings.
Methods: We performed a retrospective review of an observational cohort of 492 MoP THA patients at increased risk of developing ALTR.
Int Urogynecol J
April 2021
Biostatistics and Epidemiology Division, RTI International, Research Triangle Park, Durham, NC, USA.
J Bone Joint Surg Am
May 2020
Divisions of Adult Reconstruction (T.G.M. and B.F.R.) and Hand and Upper Extremity Surgery (C.K.), Department of Orthopaedics and Rehabilitation, University of Rochester Medical Center, Rochester, New York.
➤. Artificial intelligence (AI) provides machines with the ability to perform tasks using algorithms governed by pattern recognition and self-correction on large amounts of data to narrow options in order to avoid errors. ➤.
View Article and Find Full Text PDFSci Adv
December 2018
Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, USA.
Rift Valley fever virus (RVFV) infections in pregnant livestock cause high rates of fetal demise; miscarriage in pregnant women has also been associated with RVFV infection. To address how RVFV infection during pregnancy causes detrimental effects on the fetus, we developed a pregnant rodent model of RVFV infection. We found that pregnant rats were more susceptible to RVFV-induced death than their nonpregnant counterparts and that RVFV infection resulted in intrauterine fetal death and severe congenital abnormalities, even in pups from infected asymptomatic pregnant rats.
View Article and Find Full Text PDFCDC has updated its interim guidance for U.S. health care providers caring for infants with possible congenital Zika virus infection (1) in response to recently published updated guidance for health care providers caring for pregnant women with possible Zika virus exposure (2), unknown sensitivity and specificity of currently available diagnostic tests for congenital Zika virus infection, and recognition of additional clinical findings associated with congenital Zika virus infection.
View Article and Find Full Text PDFAdv Biol Chem
December 2016
Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, and Department of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, 5117 Centre Ave., Pittsburgh, PA 15213.
Background: Cervical cancer is the second most common cancer in women worldwide [1]. Photodynamic therapy has been used for cervical intraepithelial neoplasia with good responses, but few studies have used newer phototherapeutics. We evaluated the effectiveness of photodynamic therapy using Pc 4 in vitro and in vivo against human cervical cancer cells.
View Article and Find Full Text PDFJ Oncol Pract
September 2017
Magee-Women's Hospital of the University of Pittsburgh Medical Center; University of Pittsburgh Graduate School of Public Health; University of Pittsburgh, Pittsburgh, PA; University of Colorado Denver, Aurora, CO; Northwestern University, Chicago, IL; University of Alabama at Birmingham, Birmingham, AL; University of North Carolina, Chapel Hill, NC; University of Virginia School of Medicine, Charlottesville, VA; and University of Washington, Seattle, WA.
Purpose: Concern that patients will react negatively to the idea of palliative care is cited as a barrier to timely referral. Strategies to successfully introduce specialty palliative care to patients have not been well described. We sought to understand how gynecologic oncologists introduce outpatient specialty palliative care.
View Article and Find Full Text PDFJ Clin Oncol
July 2017
Goli Samimi, Charlisse F. Caga-anan, Michael Dean, Leah E. Mechanic, Lori M. Minasian, and Mark E. Sherman, National Cancer Institute; Lawrence C. Brody, National Human Genome Research Institute, Bethesda, MD; Marcus Q. Bernardini, Stephanie Lheureux, Patricia A. Shaw, Princess Margaret Cancer Centre, Toronto, Ontario; Janice S. Kwon, University of British Columbia; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Ian G. Campbell, Paul A. James, Masataka Takenaka, and David D. Bowtell, Peter MacCallum Cancer Centre; David D. Bowtell, University of Melbourne, Melbourne, Victoria; Georgia Chenevix-Trench, QIMR Berghofer Medical Research Institute, Brisbane, Queensland; Michael Friedlander, The Prince of Wales Hospital; Susan J. Ramus, University of New South Wales; Susan J. Ramus and David D. Bowtell, Garvan Institute of Medical Research, Sydney, New South Wales, Australia; Fergus J. Couch, Mayo Clinic, Rochester, MN; Joanne A. de Hullu and Marline G. Harmsen, Radboud University Medical Center, Nijmegen, the Netherlands; Susan M. Domchek and Ronny Drapkin, University of Pennsylvania, Philadelphia; Phuong L. Mai, Magee-Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; Heather Spencer Feigelson, Kaiser Permanente Institute for Health Research, Denver, CO; Mia M. Gaudet, American Cancer Society, Atlanta, GA; Karen Hurley and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mark E. Robson, Weill Cornell Medical College, New York, NY; Felicitas Lacbawan, Quest Diagnostics Nichols Institute, San Juan Capistrano; Thomas P. Slavin, City of Hope, Duarte, CA; Evan R. Myers, Duke University Medical Center, Durham, NC; Lisa F. Rezende, FORCE: Facing Our Risk of Cancer Empowered, Tampa; Mark E. Sherman, Mayo Clinic, Jacksonville, FL; and Elizabeth M. Swisher, University of Washington Medical Center, Seattle, WA.
In May 2016, the Division of Cancer Prevention and the Division of Cancer Control and Population Sciences, National Cancer Institute, convened a workshop to discuss a conceptual framework for identifying and genetically testing previously diagnosed but unreferred patients with ovarian cancer and other unrecognized BRCA1 or BRCA2 mutation carriers to improve the detection of families at risk for breast or ovarian cancer. The concept, designated Traceback, was prompted by the recognition that although BRCA1 and BRCA2 mutations are frequent in women with ovarian cancer, many such women have not been tested, especially if their diagnosis predated changes in testing guidelines. The failure to identify mutation carriers among probands represents a lost opportunity to prevent cancer in unsuspecting relatives through risk-reduction intervention in mutation carriers and to provide appropriate reassurances to noncarriers.
View Article and Find Full Text PDFInt J Gynaecol Obstet
June 2016
Department of Obstetrics, Gynecology and Reproductive Science, Magee-Women's Hospital of the University of Pittsburgh, Pittsburgh, PA, USA.
Objective: To construct growth curves specific for fetuses with trisomy 21 (T21) and to compare them with the reference-based standard.
Methods: A retrospective cohort study was conducted of ultrasonography examinations from women with singleton pregnancies with a confirmed diagnosis of T21 who sought care at an academic tertiary-care center in the USA between January 1, 2003, and December 31, 2013. Growth curves were constructed using linear regression and compared with the Hadlock standard.
J Am Coll Cardiol
July 2015
Leiden University Medical Center, Leiden, the Netherlands.
Cancer Cytopathol
September 2015
Department of Cytopathology, Magee-Women's Hospital of the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Gynecol Oncol Rep
January 2015
Division of Gynecologic Oncology at Magee-Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA, United States.
Background: Primary ovarian and cervical melanomas are extremely rare tumors with a poor prognosis. Diagnosis requires a high index of suspicion as presentation can mimic benign conditions clinically and other neoplasms histologically.
Cases: A 41 year-old with an adnexal mass underwent surgical staging for a stage IA ovarian melanoma.
Obstet Gynecol
June 2015
Division of Maternal-Fetal Medicine, Department of Gynecology and Obstetrics, Emory University School of Medicine, and the National Center for Emerging and Zoonotic Infectious Disease, the Office of Public Health Preparedness and Response, and the Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; the Divisions of Maternal-Fetal Medicine, Departments of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, and the University of Texas Southwestern Medical Center, Dallas, Texas; and the Division of Reproductive Infectious Disease and Obstetric Specialties, Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Objective: To estimate the maternal and fetal risks of smallpox vaccination during pregnancy.
Data Sources: MEDLINE, Web of Science, EMBASE, Global Health, ClinicalTrials.gov, and CINHAL from inception to September 2014.
J Clin Microbiol
September 2015
Magee-Women's Hospital of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Screening for cervical cancer with cytology testing has been very effective in reducing cervical cancer in the United States. For decades, the approach was an annual Pap test. In 2000, the Hybrid Capture 2 human papillomavirus (HPV) test was approved by the U.
View Article and Find Full Text PDFCancer Cytopathol
May 2015
Quest Diagnostics, Madison, New Jersey.
Background: In the United States, human papillomavirus (HPV) and Papanicolaou (Pap) testing (cotesting) for cervical screening in women ages 30 to 65 years is the preferred strategy, and cytology alone is acceptable. Recently, a proprietary automated test for identifying high-risk HPV types for primary cervical screening was approved by the US Food and Drug Administration. The objective of the current study was to document extensive cervical screening among these screening options.
View Article and Find Full Text PDFPLoS One
October 2015
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America; Magee Women's Research Institute, Pittsburgh, Pennsylvania, United States of America.
Activating mutations of Kras oncogene and deletions of Pten tumor suppressor gene play important roles in cancers of the female genital tract. We developed here new preclinical models for gynecologic cancers, using conditional (Cre-loxP) mice with floxed genetic alterations in Kras and Pten. The triple transgenic mice, briefly called MUC1KrasPten, express human MUC1 antigen as self and carry a silent oncogenic KrasG12D and Pten deletion mutation.
View Article and Find Full Text PDF